Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Systemic and Central Inflammation in AD [Phase 2]
A Phase 2 clinical trial on systemic and central inflammation in Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: An Investigation of Levetiracetam in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial investigating levetiracetam in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Home-based tDCS for Apathy in Alzheimer's Disease [NA]
A terminated clinical trial investigating home-based transcranial direct current stimulation (tDCS) for apathy in Alzheimer’s disease and re…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 multiple-dose study of PF-04360365 in mild to moderate Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers [Phase 1]
Phase 1 study assessing systemic and ocular safety and pharmacokinetics of BI 409306 in schizophrenia, Alzheimer's disease, and healthy volu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update on a buccal film formulation of montelukast for patients with Alzheimer disease, reporting safety and efficacy…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease [Phase 1, Phase 2]
Clinical trial update evaluating safety and potential therapeutic effects of CB-AC-02 in Alzheimer's disease across Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2024-04-02Clinical Trial Update: Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function [NA]
A completed clinical trial examining intermittent calorie restriction and its effects on insulin resistance and brain function biomarkers in…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program) [NA]
A completed clinical trial evaluating a non-pharmacological intervention for Alzheimer’s disease patients and family caregivers (Care Partne…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD) [Phase 2]
Phase 2 study evaluating pharmacodynamic effects of once-weekly gantenerumab in early Alzheimer's disease was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Improving the Recovery and Outcome Every Day After the ICU [NA]
Completed clinical trial related to recovery and outcomes after ICU stay; conditions include delirium and Alzheimer disease, with results po…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of choline alfoscerate in patients with Alzheimer disease.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease [Phase 2]
Phase 2 trial investigating crenezumab vs placebo in preclinical PSEN1 E280A mutation carriers with a tau PET longitudinal substudy; study c…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: The BRAIN App: Building Relationships Using Artificial Intelligence and Nostalgia [NA]
A completed clinical trial titled The BRAIN App examining AI and nostalgia for dementia-related conditions; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD [Phase 2]
A Phase 2 trial evaluating safety, tolerability, and efficacy of various doses of PQ912 in individuals with mild cognitive impairment and ea…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Montelukast Therapy on Alzheimer's Disease [Phase 2]
Phase 2 trial of montelukast for Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Lomecel-B Effects on Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating Lomecel-B for mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS research · 2024-02-08Clinical Trial Update: Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training [NA]
Clinical trial update on yogic meditation training aimed at reducing risk for Alzheimer's disease in high-risk women; study completed with r…
-
FDA approval · 2024-02-06FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Vitruvias Therapeutics, Inc.)
FDA approved a supplemental application for MEMANTINE HYDROCHLORIDE by Vitruvias Therapeutics, Inc., confirming approval for this generic me…
-
FDA approval · 2024-02-05FDA Approved: TAUVID — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Tauvid (flortaucipir F-18) enabling its use for PET imaging of tau neurofibrillary tangles in ad…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research [NA]
A completed clinical trial evaluating a relational recruitment and engagement intervention for cognitive aging research; results were posted…
-
CLINICAL_TRIALS research · 2024-01-31Clinical Trial Update: Memantine for Agitation and Aggression in Severe Alzheimer's Disease [Phase 4]
Phase 4 clinical trial update examining memantine for agitation and aggression in severe Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) [Phase 3]
Phase 3 trial of gantenerumab in early Alzheimer’s disease was terminated with results posted.
-
CLINICAL_TRIALS research · 2024-01-23Clinical Trial Update: Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology [NA]
A completed clinical trial evaluating acceptability, cost, and efficacy of STELLA-Support technology for dementia and Alzheimer disease in p…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD) [Phase 3]
Phase 3 trial evaluating long-term safety and tolerability of gantenerumab in Alzheimer's disease has been terminated with results posted.